case_images: PMC9662652_01
case_images: The pictures of patients' hands and feet before and after the treatment of dupilumab. From case 1 to case 5.
case_images: CCID-15-2421-g0001.jpg
case_images: PMC9662652_01_CCID-15-2421-g0001.jpg
case_images: f0001
case_images: Hyperkeratosis and erythema gradually recovered during the therapy (Figure 1). 
case_images: Dynamic changes of various parameters during the dupilumab therapy. The sequence of five charts was as follows: (A) Eosinophils, (B) IgE, (C) HECSI, (D) PESCI and (E) PP-NRS.
case_images: CCID-15-2421-g0002.jpg
case_images: PMC9662652_01_CCID-15-2421-g0002.jpg
case_images: f0002
case_images: The pruritus of all the patients was also markedly alleviated, which obviously improved the life quality of patients (Figure 2).